<ENAMEX TYPE="ORGANIZATION">HPB Associates Limited Partnership</ENAMEX>, a <ENAMEX TYPE="LOCATION">New York</ENAMEX> investment partnership, said it raised its stake in <ENAMEX TYPE="ORGANIZATION">Nu-Med Inc.</ENAMEX> to 9.89% of the common shares outstanding.
In a <ENAMEX TYPE="ORGANIZATION">Securities and Exchange Commission</ENAMEX> filing, <ENAMEX TYPE="ORGANIZATION">HPB</ENAMEX> said it holds 874,800 Nu-Med common shares, including 298,000 purchased from Aug. 18 to Sept. 22 for $6.28 to $7.185 each.
In August <ENAMEX TYPE="ORGANIZATION">HPB</ENAMEX> said that it acquired its 6.5% Nu-Med stake as an investment but that it may reconsider its position with respect to the company.
In the current filing, <ENAMEX TYPE="ORGANIZATION">HPB</ENAMEX> said it may consider actions it could take alone or with others with respect to its Nu-Med stake.
In national over the counter trading, Nu-Med closed yesterday at $6.75 a share, up 25 cents.
<ENAMEX TYPE="PERSON">Nu-Med</ENAMEX>'s chief financial officer, <ENAMEX TYPE="LOCATION">Yoran Dor</ENAMEX>, said the health-care services concern welcomed <ENAMEX TYPE="ORGANIZATION">HPB</ENAMEX>'s added investment. He said the officers and directors of Nu-Med control 50.1% of the company's 10 million shares outstanding.
